▶ 調査レポート

皮膚灌流圧(SPP)測定装置のグローバル市場(~2027):付属品&消耗品、システム

• 英文タイトル:Skin Perfusion Pressure Testing Devices Market Research Report by Product Type, Mode, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Skin Perfusion Pressure Testing Devices Market Research Report by Product Type, Mode, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「皮膚灌流圧(SPP)測定装置のグローバル市場(~2027):付属品&消耗品、システム」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2303L009
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、221ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の本調査資料によると、皮膚灌流圧(SPP)測定装置の世界市場規模は2021年に229.91百万ドル、2022年に251.47百万ドルとなり、その後CAGR 9.55%で成長して2027年までに397.52百万ドルに到達する見通しです。本書では、世界の皮膚灌流圧(SPP)測定装置市場について多面的に調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品タイプ別分析(付属品&消耗品、システム)、モード別分析(カート型デバイス、ポータブル型デバイス)、エンドユーザー別分析(クリニック、診断センター、病院、外来センター)、地域別分析(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)、競争状況、企業情報などの項目をまとめています。なお、本書には、Biomedix、CorVascular Diagnostics, LLC、ELCAT、Koven Technology, Inc.、Moor Instruments、Newman Medical、Perimed AB、Promed Group Co., Ltd.、Shenzhen Bestman Instrument Co., ltd.、Shenzhen Ricso Technology Co., Ltd.、Vasamed Incorporated、Viasonixなどの企業情報を掲載しています。

・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の皮膚灌流圧(SPP)測定装置市場規模:製品タイプ別
- 付属品&消耗品の市場規模
- システムの市場規模
・世界の皮膚灌流圧(SPP)測定装置市場規模:モード別
- カート型デバイスの市場規模
- ポータブル型デバイスの市場規模
・世界の皮膚灌流圧(SPP)測定装置市場規模:エンドユーザー別
- クリニックにおける市場規模
- 診断センターにおける市場規模
- 病院における市場規模
- 外来センターにおける市場規模
・世界の皮膚灌流圧(SPP)測定装置市場規模:地域別
- 南北アメリカの皮膚灌流圧(SPP)測定装置市場規模
アメリカの皮膚灌流圧(SPP)測定装置市場規模
カナダの皮膚灌流圧(SPP)測定装置市場規模
ブラジルの皮膚灌流圧(SPP)測定装置市場規模
...
- アジア太平洋の皮膚灌流圧(SPP)測定装置市場規模
日本の皮膚灌流圧(SPP)測定装置市場規模
中国の皮膚灌流圧(SPP)測定装置市場規模
インドの皮膚灌流圧(SPP)測定装置市場規模
韓国の皮膚灌流圧(SPP)測定装置市場規模
台湾の皮膚灌流圧(SPP)測定装置市場規模
...
- ヨーロッパ/中東/アフリカの皮膚灌流圧(SPP)測定装置市場規模
イギリスの皮膚灌流圧(SPP)測定装置市場規模
ドイツの皮膚灌流圧(SPP)測定装置市場規模
フランスの皮膚灌流圧(SPP)測定装置市場規模
ロシアの皮膚灌流圧(SPP)測定装置市場規模
...
- その他地域の皮膚灌流圧(SPP)測定装置市場規模
・競争状況
・企業情報

The Global Skin Perfusion Pressure Testing Devices Market size was estimated at USD 229.91 million in 2021 and expected to reach USD 251.47 million in 2022, and is projected to grow at a CAGR 9.55% to reach USD 397.52 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Skin Perfusion Pressure Testing Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product Type, the market was studied across Accessories & Consumables and Systems. The Accessories & Consumables is further studied across Electrodes, Pressure Cuffs, and Probes. The Systems is further studied across Laser Doppler SPP System, Photo plethysmography System, and Ultrsound System.

Based on Mode, the market was studied across Cart-based Devices and •Portable Devices.

Based on End User, the market was studied across Clinics, Diagnostics Centres, Hospitals, and Outpatient Centres.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Skin Perfusion Pressure Testing Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Skin Perfusion Pressure Testing Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Skin Perfusion Pressure Testing Devices Market, including Biomedix, CorVascular Diagnostics, LLC, ELCAT, Koven Technology, Inc., Moor Instruments, Newman Medical, Perimed AB, Promed Group Co., Ltd., Shenzhen Bestman Instrument Co., ltd., Shenzhen Ricso Technology Co., Ltd., Vasamed Incorporated, and Viasonix.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Skin Perfusion Pressure Testing Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Skin Perfusion Pressure Testing Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Skin Perfusion Pressure Testing Devices Market?
4. What is the competitive strategic window for opportunities in the Global Skin Perfusion Pressure Testing Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Skin Perfusion Pressure Testing Devices Market?
6. What is the market share of the leading vendors in the Global Skin Perfusion Pressure Testing Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Skin Perfusion Pressure Testing Devices Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing number of diabetes patients worldwide
5.1.1.2. Increasing penetration of the devices in hospitals and ambulatory surgical centers
5.1.1.3. Potential demand attributed to benefits over conventional techniques
5.1.2. Restraints
5.1.2.1. Dearth of skilled and trained professional
5.1.3. Opportunities
5.1.3.1. Ongoing demand for minimally and non-invasive techniques worldwide
5.1.3.2. Rapid technological advancements and benefits of portable devices
5.1.4. Challenges
5.1.4.1. Lengthy and time consuming regulatory process
5.2. Cumulative Impact of COVID-19

6. Skin Perfusion Pressure Testing Devices Market, by Product Type
6.1. Introduction
6.2. Accessories & Consumables
6.3.1. Electrodes
6.3.2. Pressure Cuffs
6.3.3. Probes
6.3. Systems
6.4.1. Laser Doppler SPP System
6.4.2. Photo plethysmography System
6.4.3. Ultrsound System

7. Skin Perfusion Pressure Testing Devices Market, by Mode
7.1. Introduction
7.2. Cart-based Devices
7.3. •Portable Devices

8. Skin Perfusion Pressure Testing Devices Market, by End User
8.1. Introduction
8.2. Clinics
8.3. Diagnostics Centres
8.4. Hospitals
8.5. Outpatient Centres

9. Americas Skin Perfusion Pressure Testing Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Skin Perfusion Pressure Testing Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Skin Perfusion Pressure Testing Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Biomedix
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. CorVascular Diagnostics, LLC
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. ELCAT
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Koven Technology, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Moor Instruments
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Newman Medical
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Perimed AB
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Promed Group Co., Ltd.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Shenzhen Bestman Instrument Co., ltd.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Shenzhen Ricso Technology Co., Ltd.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Vasamed Incorporated
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Viasonix
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing